Bile duct obstruction associated with pancreatitis in 46 dogs

被引:16
作者
Wilkinson, Ashley R. [1 ]
DeMonaco, Stefanie M. [1 ]
Panciera, David L. [1 ]
Otoni, Cristiane C. [2 ]
Leib, Michael S. [1 ]
Larson, Martha M. [1 ]
机构
[1] Virginia Maryland Coll Vet Med, Dept Small Anim Clin Sci, Blacksburg, VA USA
[2] VCA Arboretum View Anim Hosp, Downers Grove, IL USA
关键词
bile duct obstruction; rupture; hepatology; hyperbilirubinemia; pancreas; BILIARY-TRACT OBSTRUCTION; SECONDARY;
D O I
10.1111/jvim.15879
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Pancreatitis is a common cause of extrahepatic bile duct obstruction (EHBDO) in dogs. Information describing the clinical course of dogs with pancreatitis associated bile duct obstruction (PABDO) is limited. Objectives To describe the clinical course of PABDO in dogs and determine if presumed markers of disease severity are predictors of survival. Animals Forty-six client-owned dogs with PABDO. Methods A retrospective review of medical records from dogs diagnosed with PABDO was performed. Data, including clinical signs and biochemical changes, were collected 6 times throughout the course of disease. Outcome was defined as either survival (discharge from the hospital) or death. Results Thirty-three (79%) out of 42 dogs with PABDO survived. Thirty-one (94%) of the 33 dogs that survived received medical management alone. Time from onset of clinical signs to initial documented increase in serum bilirubin concentration, peak bilirubin elevation, and initial decline in serum bilirubin concentration were 7 (median), 8, and 15 days, respectively. The median number of days from onset of clinical signs to outcome date was 13. Clinical signs of fever, vomiting, and anorexia were decreased in frequency from the onset of clinical signs to the time of peak bilirubin. Median bile duct dilatation at the time of ultrasonographic diagnosis of PABDO and peak bilirubin were not different between survivors (7.6 mm, 11.7 mg/dL) and nonsurvivors (6 mm, 10.6 mg/dL,P= .12,P= .8). Conclusions Dogs with PABDO often have a prolonged course of illness and improve clinically despite biochemical evidence of progression of EHBDO.
引用
收藏
页码:1794 / 1800
页数:7
相关论文
共 24 条
[1]  
Abdallah Abdul A, 2007, HPB (Oxford), V9, P421, DOI 10.1080/13651820701774883
[2]   Initial experience with endoscopic retrograde cholangiography and endoscopic retrograde biliary stenting for treatment of extrahepatic bile duct obstruction in dogs [J].
Berent, Allyson ;
Weisse, Chick ;
Schattner, Mark ;
Gerdes, Hans ;
Chapman, Peter ;
Kochman, Michael .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 246 (04) :436-446
[3]   PLATELET FUNCTIONAL-CHANGES SECONDARY TO HEPATOCHOLESTASIS AND ELEVATION OF SERUM BILE-ACIDS [J].
BOWEN, DJ ;
CLEMMONS, RM ;
MEYER, DJ ;
DORSEYLEE, MR .
THROMBOSIS RESEARCH, 1988, 52 (06) :649-654
[4]   Clinical, ultrasonographic, and laboratory findings associated with gallbladder disease and rupture in dogs: 45 cases (1997-2007) [J].
Crews, Laura J. ;
Feeney, Daniel A. ;
Jessen, Carl R. ;
Rose, Nathan D. ;
Matise, Ilze .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2009, 234 (03) :359-366
[5]  
CRIBB AE, 1988, CAN VET J, V29, P654
[6]   Evaluation of SNAP cPL, Spec cPL, VetScan cPL Rapid Test, and Precision PSL Assays for the Diagnosis of Clinical Pancreatitis in Dogs [J].
Cridge, H. ;
MacLeod, A. G. ;
Pachtinger, G. E. ;
Mackin, A. J. ;
Sullivant, A. M. ;
Thomason, J. M. ;
Archer, T. M. ;
Lunsford, K. V. ;
Rosenthal, K. ;
Wills, R. W. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2018, 32 (02) :658-664
[7]   EXTRAHEPATIC BILIARY-TRACT OBSTRUCTION - A RETROSPECTIVE STUDY OF 45 CASES (1983-1993) [J].
FAHIE, MA ;
MARTIN, RA .
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 1995, 31 (06) :478-482
[8]   IRREVERSIBLE BINDING OF CONJUGATED BILIRUBIN TO ALBUMIN IN CHOLESTATIC RATS [J].
GAUTAM, A ;
SELIGSON, H ;
GORDON, ER ;
SELIGSON, D ;
BOYER, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :873-877
[9]  
Hess RS, 1998, J AM VET MED ASSOC, V213, P665
[10]  
Kanda H, 1996, HEPATO-GASTROENTEROL, V43, P235